explore -WSS

explore

author：entertainment 2025-09-27 16:49:30 - browse：7

Vivistim and Lead — A small Texas company is testing whether pairing vagus nerve stimulation with rehabilitation exercise can restore movement in people who have had a stroke. STAT/MicroTransponder, Inc.

Despite being forced by Hurricane Irma to close its outpatient facilities for several days, the Mayo Clinic in Jacksonville, Fla., is expected to forge ahead this month with a pivotal clinical trial testing whether an electrical implant can rewire the brains of stroke patients so they can use their arms and hands again.

If the patients who receive implants regain significantly more function than those who get only standard rehabilitation, it will show that stroke-damaged brain circuits can be bypassed like shorts in a circuit board, with healthy neurons coaxed into performing the job of those fried by stroke.

Although the results might not be make-or-break for the little 11-year-old Texas company sponsoring the trial (called MicroTransponder, the company’s also testing whether an electrical implant can alleviate tinnitus), there will be more evidence of whether “electroceuticals” — electrical stimuli tailored to treat diseases — work beyond their current use in controlling pain and a few other conditions or will fall short of the buzz surrounding them.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Does Medicare's free annual wellness visit do any good?

WSS

Flash flooding emergencies prompt evacuations in Kentucky, Tennessee

Lifetime voting ban for felony convictions struck down in Mississippi

What to know about 'Guardians of the Galaxy Vol. 3' as it hits Disney+

Mass General, Mayo Clinic look to monetize custom

Medicare drug price lawsuits could be good politics for Biden

Russian court extends detention of American musician

explore

explore

focus

Psychedelics group wrestles with new pharma identity

Slain Parkland victim's father speaks out following reenactment

Alkermes shareholders re

Medical mystery: When an infection after surgery isn’t what it seems

How one medical school became remarkably diverse

FDA sets aggressive timeline for overhauling inspection procedures

Tori Bowie and the unacceptable rates of Black maternal death

There's an unseen cost to disruptive road

As demand for Covid shots wanes, Moderna seeks its next success

Sanofi to acquire U.S. biotech Inhibrx in $2.2 billion deal

focus

Lifetime voting ban for felony convictions struck down in Mississippi

California Joshua trees severely burned in massive wildfire

There's an unseen cost to disruptive road

HPV vaccine, cervical cancer study delivers historic results

What causes osteoarthritis? Researchers study link to brain protein

Medicare bonuses could stop drug shortages under Senate plan

Wikipedia

hotspot

focus

hotspot